Novotech

CBR International is a technical consulting firm specializing in FDA representation, strategic program development, process optimization, and clinical program development for the biotechnology and pharmaceutical sectors. The company is composed of a diverse team of scientists, engineers, clinicians, and regulatory experts who are committed to facilitating scientific learning and collaboration. By providing support in global product development, clinical oversight, and regulatory operations, CBR International aims to enhance the efficiency and effectiveness of drug development processes, ultimately leading to cost-effective and timely outcomes for its clients.

EastHORN Clinical Services is a full-service contract research organization (CRO) that specializes in supporting pharmaceutical and biotechnology companies in Europe. The firm offers a comprehensive range of services, including clinical monitoring, project management, and regulatory services. EastHORN focuses on various therapeutic areas, including cardiovascular diseases, dermatology, endocrinology, metabolic diseases, gastroenterology, and immunology. The company is dedicated to facilitating the development of drugs and therapies, ensuring that complex studies are conducted efficiently and within budgetary constraints.

NCGS, Incorporated is an international full-service clinical research organization (CRO) that offers comprehensive clinical development support to pharmaceutical, biotechnology, medical device, and diagnostic companies. With over 30 years of experience, NCGS is recognized for its distinctive business model, which emphasizes the expertise of its highly tenured staff to ensure studies are completed on time, within budget, and to the highest quality standards. The company has successfully supported the approval or expanded labeling of 34 products without receiving any 483 citations, highlighting its commitment to excellence. As a WBENC-certified diversity supplier, NCGS values the importance of a trusted partnership with its clients, understanding the complexities of the life sciences industry. The organization is dedicated to protecting research subjects, capturing quality data, and maintaining scientific integrity, driven by a commitment to treat each product as if it could impact the lives of their own family members. NCGS operates across various clinical development areas, including oncology-hematology, infectious disease, critical care, and CNS, catering to both adult and pediatric populations.

Prospection Pty Ltd, established in 2009, is a Sydney-based software company specializing in healthcare data analytics. It develops SaaS platforms that transform complex healthcare data into actionable insights. Key products include PharmDash, which analyzes patient drug usage and treatment progression, and PharmMap, which integrates commercial and operational data using geospatial mapping. Prospection serves pharmaceutical companies, research institutions, and hospitals worldwide, aiding them in optimizing drug performance and enhancing patient outcomes.

ObvioHealth is a global digital health organization focused on enhancing clinical trials through innovative technology. The company provides a mobile clinical study application that facilitates site-less trial designs, enabling participants to engage in remote monitoring from their homes. This application supports continuous data collection between clinic visits, ensuring robust data acquisition and improved participant compliance. By utilizing features such as text messaging and chatbots, ObvioHealth fosters daily interaction with trial subjects, enhancing their involvement in the process. The platform also integrates seamlessly with various health devices, including smartwatches and activity trackers, which aids in collecting real-world data. Additionally, participants can manage lab visit scheduling and receive compensation through their connected accounts. By streamlining communication through chat or video, ObvioHealth significantly improves the clinical trial experience for both sponsors and participants, leading to faster recruitment and reduced trial completion times.

Clinical Network Services (CNS) Pty Ltd is a Brisbane-based contract research organization specializing in the planning and execution of Phase I and II clinical trials primarily in Australia and New Zealand. Established in 1998, CNS has extensive experience in managing early-stage clinical trials, having successfully undertaken over 145 projects. The company offers a comprehensive range of services, including protocol development, study management, data management, and trial planning, which encompasses site feasibility assessments and clinical trial insurance. CNS is particularly advantageous for small to medium-sized biotech firms due to Australia’s streamlined regulatory environment, allowing for quicker proof-of-concept timelines compared to more complex processes in the United States and Europe. The firm also provides targeted services like trial manager support and bespoke product development through its "BioDesk" initiative, designed to assist clients in efficiently navigating the clinical landscape and achieving their commercial objectives. With a strong market presence, CNS has become a preferred partner for biotechnology companies looking to advance their clinical programs.